Vimian Group AB (publ) (VIMGF)

OTCMKTS · Delayed Price · Currency is USD
3.620
0.00 (0.00%)
At close: Nov 21, 2024
60.89%
Market Cap 2.04B
Revenue (ttm) 393.03M
Net Income (ttm) 285.52K
Shares Out n/a
EPS (ttm) 0.00
PE Ratio 7,142.12
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 680
Open 3.620
Previous Close n/a
Day's Range 3.620 - 3.620
52-Week Range 2.250 - 4.120
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Feb 13, 2025

About Vimian Group AB

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the I... [Read more]

Sector Healthcare
Founded 2020
Employees 1,100
Stock Exchange OTCMKTS
Ticker Symbol VIMGF
Full Company Profile

Financial Performance

Financial numbers in EUR Financial Statements

News

There is no news available yet.